Analysis of the RelA:CBP/p300 Interaction Reveals Its Involvement in NF-κB-Driven Transcription

PLoS Biology

Volumn 11, Issue 9, 2013, Pages

  Mukherjee, Sulakshana P ^a,b   Behar, Marcelo ^a   Birnbaum, Harry A ^a   Hoffmann, Alexander ^a   Wright, Peter E ^b   Ghosh, Gourisankar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DNA; E1A ASSOCIATED P300 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA;

ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; FEEDBACK SYSTEM; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HYDROPHOBICITY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; ISOTHERMAL TITRATION CALORIMETRY; MATHEMATICAL MODEL; MOUSE; MUTANT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; E1A-ASSOCIATED P300 PROTEIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PHOSPHOPROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84884586171     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001647     Document Type: Article

References (77)

1. Hayden MS, West AP, Ghosh S, (2006) NF-kappaB and the immune response. Oncogene 25: 6758-6780.
2. Natoli G, Saccani S, Bosisio D, Marazzi I, (2005) Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6: 439-445.
3. Siggers T, Chang AB, Teixeira A, Wong D, Williams KJ, et al. (2012) Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-kappaB family DNA binding. Nat Immunol 13: 95-102.
4. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, et al. (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A 94: 2927-2932.
5. Yamit-Hezi A, Dikstein R, (1998) TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB. EMBO J 17: 5161-5169.
6. Guermah M, Malik S, Roeder RG, (1998) Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1. Mol Cell Biol 18: 3234-3244.
7. Naar AM, Beaurang PA, Zhou S, Abraham S, Solomon W, et al. (1999) Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 398: 828-832.
8. Merika M, Williams AJ, Chen G, Collins T, Thanos D, (1998) Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell 1: 277-287.
9. Blobel GA, (2000) CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95: 745-755.
10. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, et al. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
11. Hottiger MO, Felzien LK, Nabel GJ, (1998) Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. EMBO J 17: 3124-3134.
12. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, et al. (2009) ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854-858.
13. Jin F, Li Y, Ren B, Natarajan R, (2011) PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers. Proc Natl Acad Sci U S A 108: 5290-5295.
14. Schmitz ML, Baeuerle PA, (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J 10: 3805-3817.
15. Vallabhapurapu S, Karin M, (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
16. van Essen D, Engist B, Natoli G, Saccani S, (2009) Two modes of transcriptional activation at native promoters by NF-kappaB p65. PLoS Biol 7: e73 doi:10.1371/journal.pbio.1000073.
17. Schmitz ML, dos Santos Silva MA, Altmann H, Czisch M, Holak TA, et al. (1994) Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation. J Biol Chem 269: 25613-25620.
18. Zheng C, Yin Q, Wu H, (2011) Structural studies of NF-kappaB signaling. Cell Res 21: 183-195.
19. Dong J, Jimi E, Zhong H, Hayden MS, Ghosh S, (2008) Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. Genes Dev 22: 1159-1173.
20. Zhong H, Voll RE, Ghosh S, (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661-671.
21. Dames SA, Martinez-Yamout M, De Guzman RN, Dyson HJ, Wright PE, (2002) Structural basis for Hif-1 alpha/CBP recognition in the cellular hypoxic response. Proc Natl Acad Sci U S A 99: 5271-5276.
22. Freedman SJ, Sun ZY, Poy F, Kung AL, Livingston DM, et al. (2002) Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc Natl Acad Sci U S A 99: 5367-5372.
23. Wojciak JM, Martinez-Yamout MA, Dyson HJ, Wright PE, (2009) Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains. EMBO J 28: 948-958.
24. De Guzman RN, Martinez-Yamout MA, Dyson HJ, Wright PE, (2004) Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites. J Biol Chem 279: 3042-3049.
25. De Guzman RN, Wojciak JM, Martinez-Yamout MA, Dyson HJ, Wright PE, (2005) CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. Biochemistry 44: 490-497.
26. Yao J, Chung J, Eliezer D, Wright PE, Dyson HJ, (2001) NMR structural and dynamic characterization of the acid-unfolded state of apomyoglobin provides insights into the early events in protein folding. Biochemistry 40: 3561-3571.
27. Plevin MJ, Mills MM, Ikura M, (2005) The LxxLL motif: a multifunctional binding sequence in transcriptional regulation. Trends Biochem Sci 30: 66-69.
28. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, et al. (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137: 47-59.
29. Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, et al. (2004) Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem 279: 49571-49574.
30. Martin M, Rehani K, Jope RS, Michalek SM, (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777-784.
31. Mattioli I, Geng H, Sebald A, Hodel M, Bucher C, et al. (2006) Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. J Biol Chem 281: 6175-6183.
32. Goto NK, Zor T, Martinez-Yamout M, Dyson HJ, Wright PE, (2002) Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain. J Biol Chem 277: 43168-43174.
33. Lee CW, Arai M, Martinez-Yamout MA, Dyson HJ, Wright PE, (2009) Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. Biochemistry 48: 2115-2124.
34. Moreno R, Sobotzik JM, Schultz C, Schmitz ML, (2010) Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucleic Acids Res 38: 6029-6044.
35. Mao X, Gluck N, Li D, Maine GN, Li H, et al. (2009) GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA. Genes Dev 23: 849-861.
36. Geng H, Wittwer T, Dittrich-Breiholz O, Kracht M, Schmitz ML, (2009) Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep 10: 381-386.
37. Ouaaz F, Li M, Beg AA, (1999) A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death. J Exp Med 189: 999-1004.
38. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, et al. (2009) A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138: 114-128.
39. Hoffmann A, Levchenko A, Scott ML, Baltimore D, (2002) The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298: 1241-1245.
40. Werner SL, Barken D, Hoffmann A, (2005) Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309: 1857-1861.
41. Giorgetti L, Siggers T, Tiana G, Caprara G, Notarbartolo S, et al. (2010) Noncooperative interactions between transcription factors and clustered DNA binding sites enable graded transcriptional responses to environmental inputs. Mol Cell 37: 418-428.
42. Barken D, Wang CJ, Kearns J, Cheong R, Hoffmann A, et al. (2005) Comment on "Oscillations in NF-kappaB signaling control the dynamics of gene expression". Science 308: 52 author reply 52.
43. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, et al. (2004) Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 306: 704-708.
44. Holmqvist PH, Mannervik M, (2013) Genomic occupancy of the transcriptional co-activators p300 and CBP. Transcription 4: 18-23.
45. Tompa P, Fuxreiter M, (2008) Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. Trends Biochem Sci 33: 2-8.
46. Freedman SJ, Sun ZY, Kung AL, France DS, Wagner G, et al. (2003) Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat Struct Biol 10: 504-512.
47. Ferreon JC, Lee CW, Arai M, Martinez-Yamout MA, Dyson HJ, et al. (2009) Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc Natl Acad Sci U S A 106: 6591-6596.
48. Lee CW, Ferreon JC, Ferreon AC, Arai M, Wright PE, (2010) Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proc Natl Acad Sci U S A 107: 19290-19295.
49. Zhong H, May MJ, Jimi E, Ghosh S, (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636.
50. Chen LF, Mu Y, Greene WC, (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 21: 6539-6548.
51. Chen LF, Williams SA, Mu Y, Nakano H, Duerr JM, et al. (2005) NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 25: 7966-7975.
52. Ainbinder E, Revach M, Wolstein O, Moshonov S, Diamant N, et al. (2002) Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. Mol Cell Biol 22: 6354-6362.
53. Jacque E, Tchenio T, Piton G, Romeo PH, Baud V, (2005) RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc Natl Acad Sci U S A 102: 14635-14640.
54. Anrather J, Racchumi G, Iadecola C, (2005) cis-acting, element-specific transcriptional activity of differentially phosphorylated nuclear factor-kappa B. J Biol Chem 280: 244-252.
55. Chen FE, Ghosh G, (1999) Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene 18: 6845-6852.
56. Sen R, Baltimore D, (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
57. Huth JR, Bewley CA, Jackson BM, Hinnebusch AG, Clore GM, et al. (1997) Design of an expression system for detecting folded protein domains and mapping macromolecular interactions by NMR. Protein Sci 6: 2359-2364.
58. Koenig BW, Rogowski M, Louis JM, (2003) A rapid method to attain isotope labeled small soluble peptides for NMR studies. J Biomol NMR 26: 193-202.
59. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
60. Keller RLJ (2005) Optimizing the process of NMR spectrum analysis and computer aided resonance assignment. Zürich: ETH. 150 p.
61. Cavanaugh J (2006) Protein NMR spectroscopy principles and practice. Academic Press.
62. Zwahlen C, (1997) Methods for measurement of intermolecular NOEs by multinuclear NMR spectroscopy: application to a bacteriophage λ N-Peptide/boxB RNA complex. Journal of the American Chemical Society 119: 6711-6721.
63. Guntert P, (2004) Automated NMR structure calculation with CYANA. Methods Mol Biol 278: 353-378.
64. Herrmann T, Guntert P, Wuthrich K, (2002) Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol 319: 209-227.
65. Shen Y, Delaglio F, Cornilescu G, Bax A, (2009) TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR 44: 213-223.
66. Case DA, Cheatham TE, (2005) The Amber biomolecular simulation programs. J Comput Chem 26: 1668-1688.
67. Case DA, Darden TE, Cheatham TE,. (2008) AMBER 10. 10 ed. San Francisco.
68. Tsui V, Case DA, (2000) Theory and applications of the generalized Born solvation model in macromolecular simulations. Biopolymers 56: 275-291.
69. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM, (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8: 477-486.
70. Gapuzan ME, Schmah O, Pollock AD, Hoffmann A, Gilmore TD, (2005) Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras. Oncogene 24: 6574-6583.
71. Ghisletti S, Huang W, Jepsen K, Benner C, Hardiman G, et al. (2009) Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev 23: 681-693.
72. Trapnell C, Pachter L, Salzberg SL, (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
73. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515.
74. Shih VF, Kearns JD, Basak S, Savinova OV, Ghosh G, et al. (2009) Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity. Proc Natl Acad Sci U S A 106: 9619-9624.
75. Kasper LH, Lerach S, Wang J, Wu S, Jeevan T, et al. (2010) CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation. EMBO J 29: 3660-3672.
76. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
77. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ, (2009) Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25: 1189-1191.